Piscium will use the fresh funds to strengthen its sales and marketing team, brand building, scale up production & operations and expand overseas
Founded by Malay Dikshit and Trupta Dikshit in 2017, Piscium manufactures a patented dental apparatus called alpha nano diamond burs. The burs are embedded with nano-sized diamonds.
It aims to reach to over 300K dentists across 5 continents with its products by 2027
Nanotech medical startup Piscium has raised INR 6 Cr as a part of its Series A funding round led by Unicorn India Ventures, along with a host of other undisclosed investors.
The IIT-Bombay incubated startup will deploy the fresh proceeds to scale up its sales and marketing team, brand building, boost production and operations as well as to expand overseas.
Founded by Malay Dikshit and Trupta Dikshit in 2017, Piscium manufactures a patented dental apparatus called alpha nano diamond burs. The burs are embedded with nano-sized diamonds. The company claims that 55% of dentists who used this bur said that it scores significantly better over their existing choice of burs in terms of procedural control, lesser time taken, lesser pressure required, longevity and overall experience.
The startup’s portfolio comprises over 10 more dental procedure products apart from the nano diamond burs. The company plans to further diversify its portfolio of dental and medical devices with the fresh infusion.
“By 2027, over 300K dentists across five continents would be using Piscium’s products as we believe that scientific acumen, strong innovation pipeline and an equally strong route to market would be our principal growth drivers,” Malay Dikshit said.
This is the first funding made by the VC fund Unicorn India Ventures since closing its INR 1,000 Cr Fund III at INR 225 Cr in September 2023. The VC firm is looking to close the fund by March.
It plans to back a total of 25 startups operating in newer sectors like climate tech, agritech, spacetech and the semiconductor ecosystem.
As per an insights10 report, India’s dental care market was valued at $653 Mn in 2022 and is estimated to touch a CAGR of 9.40% from 2022 to 2030 and will reach $1.4 Bn in 2030.
